Lentiviral vector transduced CD34+ cells ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
65	Primary immunodeficiency	2

65. Primary immunodeficiency

---

Clinical trials : 500 /  Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03601286 (ClinicalTrials.gov)	December 21, 2018	22/2/2018	Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency	Phase I/II Study of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan	Severe Combined Immunodeficiency, X-Linked	Drug: Lentiviral vector transduced CD34+ cells	Great Ormond Street Hospital for Children NHS Foundation Trust	NULL	Recruiting	8 Weeks	5 Years	Male	5	Phase 1	United Kingdom
2	NCT01381003 (ClinicalTrials.gov)	November 2011	23/6/2011	Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)	Phase I/II Gene Therapy Protocol for X-Linked Chronic Granulomatous Disease	Granulomatous Disease, Chronic, X-linked, Variant	Genetic: pCCLchimGp91s lentiviral vector transduced CD34+ cells infusion	Great Ormond Street Hospital for Children NHS Foundation Trust	NULL	Withdrawn	N/A	30 Years	Male	0	Phase 1/Phase 2	United Kingdom